Related Tags

Tags: uk + research.with.MS

Sort by: Date / Title / URL

  1. European Journal of Neurology (EJN) reports a study1 which shows that Sativex, a cannabis based medicine, significantly reduces intractable spasms and stiffness (spasticity) in people with Multiple Sclerosis
  2. Members of the National Multiple Sclerosis Society stop by Austin to talk about the advancements in M-S research.
  3. People with multiple sclerosis are backing a Norfolk and Norwich University Hospital study into whether cannabis will help them cope with the condition.
  4. A gene that helps to stave off the effects of multiple sclerosis (MS) has been discovered by scientists.
  5. Multiple sclerosis symptoms can be affected by a pair of "angel and devil" genes that fight to make a patient healthy or ill, Oxford University researchers have found.
  6. A three-year controlled study is being launched at 10 centers across the United Kingdom to further investigate the potential of the drug combination. The results of the initial trial, led by Dr. Mike Boggild at the Walton Centre in Liverpool, will be publ
  7. The United Kingdom early Mitoxantrone Copaxone trial is a controlled study which will compare combination therapy with mitoxantrone and Glatiramer Acetate (Copaxone) against high dose interferon beta treatment (Rebif 44).
  8. Doctors at Walton began treating patients with a combination of a chemotherapy drug normally used to treat cancer called mitoxantrone, with an MS anti-relapse drug Copaxone, in 2001.
  9. Clinicians from across the UK have now embarked on the world's first trial to investigate whether cannabis derivatives could play a role in slowing the progression of multiple sclerosis.
  10. Treatment of relapses in multiple sclerosis with intravenous steroids can be effectively and safely administered at home, from both patient and economic perspectives. Moreover, the trial indicates the importance of explicit and valid outcome measures of a
  11. Welcome to The Brain Research Trust's new website. We have been raising money for research into neurological diseases and conditions for over 30 years.

First / Previous / Next / Last / Page 1 of 1